KR20100067686A - 변형된 성장 호르몬 폴리펩티드 - Google Patents

변형된 성장 호르몬 폴리펩티드 Download PDF

Info

Publication number
KR20100067686A
KR20100067686A KR1020107010215A KR20107010215A KR20100067686A KR 20100067686 A KR20100067686 A KR 20100067686A KR 1020107010215 A KR1020107010215 A KR 1020107010215A KR 20107010215 A KR20107010215 A KR 20107010215A KR 20100067686 A KR20100067686 A KR 20100067686A
Authority
KR
South Korea
Prior art keywords
seq
ser
leu
glu
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020107010215A
Other languages
English (en)
Korean (ko)
Inventor
피터 아르티미우크
리차드 에이 로스
존 사이어스
Original Assignee
아스테리온 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스테리온 리미티드 filed Critical 아스테리온 리미티드
Publication of KR20100067686A publication Critical patent/KR20100067686A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020107010215A 2007-10-10 2008-09-10 변형된 성장 호르몬 폴리펩티드 Ceased KR20100067686A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US97901007P 2007-10-10 2007-10-10
US60/979,010 2007-10-10
GBGB0719818.7A GB0719818D0 (en) 2007-10-11 2007-10-11 Growth hormone fusion polypeptides
GB0719818.7 2007-10-11

Publications (1)

Publication Number Publication Date
KR20100067686A true KR20100067686A (ko) 2010-06-21

Family

ID=38787949

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107010215A Ceased KR20100067686A (ko) 2007-10-10 2008-09-10 변형된 성장 호르몬 폴리펩티드

Country Status (17)

Country Link
US (2) US8273552B2 (cg-RX-API-DMAC7.html)
EP (2) EP2886553A1 (cg-RX-API-DMAC7.html)
JP (1) JP5697983B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100067686A (cg-RX-API-DMAC7.html)
CN (1) CN101932600B (cg-RX-API-DMAC7.html)
AR (1) AR068038A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008309386A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818639A2 (cg-RX-API-DMAC7.html)
CA (1) CA2701369A1 (cg-RX-API-DMAC7.html)
DK (1) DK2209798T3 (cg-RX-API-DMAC7.html)
ES (1) ES2532600T3 (cg-RX-API-DMAC7.html)
GB (1) GB0719818D0 (cg-RX-API-DMAC7.html)
IL (1) IL203073A0 (cg-RX-API-DMAC7.html)
MX (1) MX2010003892A (cg-RX-API-DMAC7.html)
RU (1) RU2471808C2 (cg-RX-API-DMAC7.html)
TW (1) TW200918098A (cg-RX-API-DMAC7.html)
WO (1) WO2009047474A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606946D0 (en) * 2006-04-06 2006-05-17 Asterion Ltd Polypeptide antagonist
GB201104285D0 (en) 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH20A (fr) * 1888-12-05 Joseph Magnat Une pompe à bière automatique fonctionnant par la pression de l'eau
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds
CA2447632C (en) * 2000-06-16 2011-08-02 Asterion Limited Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor
ATE509097T1 (de) 2001-11-21 2011-05-15 Us Health Gewinnung von rekombinantem menschlichem parainfluenzavirus typ 1 (hpivi) aus cdna
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
WO2004090135A2 (en) 2003-04-09 2004-10-21 Asterion Limited Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
MX2007001180A (es) * 2004-07-26 2007-04-13 Asterion Ltd Enlazantes.
GB0717985D0 (en) 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
EP2288386A1 (en) * 2008-02-19 2011-03-02 Asterion Limited Modified linkers

Also Published As

Publication number Publication date
CN101932600A (zh) 2010-12-29
CN101932600B (zh) 2014-05-28
BRPI0818639A2 (pt) 2015-04-07
AR068038A1 (es) 2009-10-28
EP2209798A2 (en) 2010-07-28
WO2009047474A2 (en) 2009-04-16
CA2701369A1 (en) 2009-04-16
US20100197589A1 (en) 2010-08-05
US8273552B2 (en) 2012-09-25
JP5697983B2 (ja) 2015-04-08
IL203073A0 (en) 2010-11-30
WO2009047474A3 (en) 2010-09-02
GB0719818D0 (en) 2007-11-21
JP2011507487A (ja) 2011-03-10
ES2532600T3 (es) 2015-03-30
MX2010003892A (es) 2010-05-17
DK2209798T3 (en) 2015-03-23
TW200918098A (en) 2009-05-01
US20120322735A1 (en) 2012-12-20
EP2209798B1 (en) 2014-12-31
EP2886553A1 (en) 2015-06-24
AU2008309386A1 (en) 2009-04-16
RU2471808C2 (ru) 2013-01-10
RU2010103159A (ru) 2011-11-20

Similar Documents

Publication Publication Date Title
EP0871665B1 (en) Insulin derivatives
EP0728147B1 (en) Receptor specific atrial natriuretic peptides
CN101679504B (zh) 生长激素融合蛋白
US5665704A (en) Receptor specific atrial natriuretic peptides
KR100879553B1 (ko) 변형 폴리펩티드
CN114591415B (zh) Glp-1/gcg双受体激动剂多肽及其融合蛋白
RU2325400C2 (ru) Мультимеры рецептор-связывающих лигандов
Puett et al. hCG-receptor binding and transmembrane signaling
CN101932600B (zh) 修饰的生长激素多肽
JP2010535490A (ja) インスリン様成長因子融合タンパク質

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20100507

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130909

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20140929

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150626

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20150916

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150626

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20140929

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I